Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

Table S5 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma

<p>List of recurrent mutations with potential utility as neoantigens</p>

-д хадгалсан:

Номзүйн дэлгэрэнгүй
Үндсэн зохиолч:	Lijun Yao (15292963) (author)
Бусад зохиолчид:	Julia T. Wang (15292966) (author), Reyka G. Jayasinghe (15131798) (author), Julie O'Neal (15292969) (author), Chia-Feng Tsai (15292972) (author), Michael P. Rettig (15292975) (author), Yizhe Song (15292978) (author), Ruiyang Liu (15292981) (author), Yanyan Zhao (15292984) (author), Omar M. Ibrahim (15292987) (author), Mark A. Fiala (15032471) (author), Julie M. Fortier (15292990) (author), Siqi Chen (15292993) (author), Leah Gehrs (15292996) (author), Fernanda Martins Rodrigues (15292999) (author), Michael C. Wendl (15293002) (author), Daniel Kohnen (15293005) (author), Andrew Shinkle (15293008) (author), Song Cao (15293011) (author), Steven M. Foltz (15293014) (author), Daniel Cui Zhou (15293017) (author), Erik Storrs (15293020) (author), Matthew A. Wyczalkowski (15293023) (author), Smrithi Mani (15293026) (author), Scott R. Goldsmith (15293029) (author), Ying Zhu (15293032) (author), Mark Hamilton (15131831) (author), Tao Liu (15293035) (author), Feng Chen (15293038) (author), Ravi Vij (15293041) (author), Li Ding (15061726) (author), John F. DiPersio (15293044) (author)
Хэвлэсэн:	2025
Нөхцлүүд:	Cancer Immuno-oncology Methods and Technology Hematological Cancers Myelomas Immunotherapy Single Cell Technologies
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!

Ижил төстэй зүйлс

Table S1 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
-н: Lijun Yao (15292963)
Хэвлэсэн: (2025)

Table S2 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
-н: Lijun Yao (15292963)
Хэвлэсэн: (2025)

Table S3 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
-н: Lijun Yao (15292963)
Хэвлэсэн: (2025)

Table S4 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
-н: Lijun Yao (15292963)
Хэвлэсэн: (2025)

Table S6 from Single-Cell Discovery and Multiomic Characterization of Therapeutic Targets in Multiple Myeloma
-н: Lijun Yao (15292963)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S5 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S1 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S10 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S11 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S12 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S2 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S3 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S4 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S6 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S7 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S8 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Spreadsheet S9 from Multiomic Mapping of Acquired Chromosome 1 Copy-Number and Structural Variants to Identify Therapeutic Vulnerabilities in Multiple Myeloma
-н: Eileen M. Boyle (15015425)
Хэвлэсэн: (2025)

Supplementary Data S1 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
-н: Keiji Kurata (15055090)
Хэвлэсэн: (2025)

Supplementary Data S2 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
-н: Keiji Kurata (15055090)
Хэвлэсэн: (2025)

Supplementary Data S3 from BRD9 Degradation Disrupts Ribosome Biogenesis in Multiple Myeloma
-н: Keiji Kurata (15055090)
Хэвлэсэн: (2025)

Supplementary Table 5 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
-н: Yunlu Jia (2012017)
Хэвлэсэн: (2025)

Supplementary Table 1 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
-н: Yunlu Jia (2012017)
Хэвлэсэн: (2025)

Supplementary Table 2 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
-н: Yunlu Jia (2012017)
Хэвлэсэн: (2025)

Supplementary Table 3 from Super Enhancer-Mediated Upregulation of <i>HJURP</i> Promotes Growth and Survival of t(4;14)-Positive Multiple Myeloma
-н: Yunlu Jia (2012017)
Хэвлэсэн: (2025)

Supplementary table 5 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
-н: Wei Chen (15053713)
Хэвлэсэн: (2025)

Supplementary table 6 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
-н: Wei Chen (15053713)
Хэвлэсэн: (2025)

Supplementary table 7 from Single-Cell Transcriptomics Reveals Immune Reconstitution in Patients with R/R T-ALL/LBL Treated with Donor-Derived CD7 CAR-T Therapy
-н: Wei Chen (15053713)
Хэвлэсэн: (2025)

Discovery and Characterization of Novel BLIMP‑1 Heterobifunctional Ligand-Directed Degraders
-н: Bryan J. Simmons (22676881)
Хэвлэсэн: (2025)

Supplementary Data from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
-н: Ti Wen (15130158)
Хэвлэсэн: (2025)

Correlation between duration of first-line treatment with daratumumab, lenalidomide, and dexamethasone and overall survival in patients with transplant-ineligible multiple myeloma in Japan
-н: Kazuhito Suzuki (22688384)
Хэвлэсэн: (2025)

Supplementary Table S1 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
-н: Yibin Dai (16374331)
Хэвлэсэн: (2025)

Supplementary Table S2 from Integrative Single-Cell and Bulk Transcriptomes Analyses Identify Intrinsic HNSCC Subtypes with Distinct Prognoses and Therapeutic Vulnerabilities
-н: Yibin Dai (16374331)
Хэвлэсэн: (2025)

Table S5 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
-н: Stéphane Fattori (15048281)
Хэвлэсэн: (2025)

Supplementary Tables S1-S11 from Adult Low-Hypodiploid Acute Lymphoblastic Leukemia Emerges from Preleukemic <i>TP53</i>-Mutant Clonal Hematopoiesis
-н: Rathana Kim (15135915)
Хэвлэсэн: (2025)

File_S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
-н: Stéphane Fattori (15048281)
Хэвлэсэн: (2025)

Table S1 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
-н: Stéphane Fattori (15048281)
Хэвлэсэн: (2025)

Table S2 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
-н: Stéphane Fattori (15048281)
Хэвлэсэн: (2025)

Table S3 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
-н: Stéphane Fattori (15048281)
Хэвлэсэн: (2025)

Table S4 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
-н: Stéphane Fattori (15048281)
Хэвлэсэн: (2025)

Table S6 from CD25<sup>high</sup> Effector Regulatory T Cells Hamper Responses to PD-1 Blockade in Triple-Negative Breast Cancer
-н: Stéphane Fattori (15048281)
Хэвлэсэн: (2025)

Cannot write session to /tmp/vufind_sessions/sess_1if4hogfu3els1cjkqp4rlk4hu